SCHEMBL9920465

SCHEMBL9920465

CC(=O)Oc1ccc2oc3c(c2c1)CCCNC3=O

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.65
PRKD1 Q15139 3/20 0.65
LMNA P02545 3/20 0.65
HTT P42858 2/20 0.65
TP53 P04637 1/20 0.65
CDK5 Q00535 1/20 0.65
CDK5R1 Q15078 1/20 0.65
PRKD2 Q9BZL6 1/20 0.65
L3MBTL1 Q9Y468 1/20 0.65
KDM4E B2RXH2 7/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
GAA P10253 5/20 0.46
NPSR1 Q6W5P4 2/20 0.46
TSHR P16473 1/20 0.46
RXFP1 Q9HBX9 1/20 0.46
MAPT P10636 2/20 0.44
HSD17B10 Q99714 2/20 0.44
MAPK1 P28482 1/20 0.44
GFER P55789 1/20 0.44
GLA P06280 4/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9904237 0.85 ALDH1A1 (0.67) ALDH1A1PRKD1LMNAHTTTP53
SCHEMBL9904134 0.82 PRKD1 (0.67) ALDH1A1PRKD1LMNAHTTTP53
SCHEMBL9904117 0.80 LMNA (0.59) ALDH1A1PRKD1LMNAHTTTP53
SCHEMBL31060198 0.79 PRKD1 (1.00) ALDH1A1PRKD1LMNAHTTTP53
SCHEMBL15471995 0.79 ALDH1A1 (0.71) ALDH1A1PRKD1LMNAHTTTP53
SCHEMBL9904268 0.79 PRKD1 (1.00) ALDH1A1PRKD1LMNAHTTTP53
SCHEMBL9920606 0.78 ALDH1A1 (0.55) ALDH1A1PRKD1LMNAHTTTP53
SCHEMBL15466407 0.77 ALDH1A1 (0.56) ALDH1A1LMNAHTTTP53KDM4E
SCHEMBL9904242 0.77 PRKD1 (0.59) ALDH1A1PRKD1LMNAHTTTP53
SCHEMBL9904150 0.75 PRKD1 (1.00) ALDH1A1PRKD1LMNAHTTTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9840515-B2 Protein kinase D inhibitors University of Pittsburgh—of the Commonwealth System of Higher Education (US) 2017-12-12 US disclosed
US-9840515-B2 Protein kinase D inhibitors University of Pittsburgh—of the Commonwealth System of Higher Education (US) 2017-12-12 US disclosed
US-20140045821-A1 PROTEIN KINASE D INHIBITORS UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION 2014-02-13 US disclosed
US-20140045821-A1 PROTEIN KINASE D INHIBITORS UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION 2014-02-13 US disclosed
WO-2012078859-A2 PROTEIN KINASE D INHIBITORS UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2012-06-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140045821-A1 PROTEIN KINASE D INHIBITORS PRKCD, PRKD1, PRKD2 ALDH1A1 4548/4885PRKD1 2/4885LMNA 3108/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.